rs13306411
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000329125.6(GP1BA):c.256C>T(p.Leu86Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000565 in 1,614,054 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
ENST00000329125.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GP1BA | NM_000173.7 | c.256C>T | p.Leu86Phe | missense_variant | 2/2 | ENST00000329125.6 | NP_000164.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GP1BA | ENST00000329125.6 | c.256C>T | p.Leu86Phe | missense_variant | 2/2 | 1 | NM_000173.7 | ENSP00000329380 | P1 | |
CHRNE | ENST00000649830.1 | c.-888+1482G>A | intron_variant | ENSP00000496907 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000245 AC: 61AN: 249204Hom.: 0 AF XY: 0.000215 AC XY: 29AN XY: 135194
GnomAD4 exome AF: 0.000592 AC: 866AN: 1461690Hom.: 19 Cov.: 37 AF XY: 0.000584 AC XY: 425AN XY: 727124
GnomAD4 genome AF: 0.000302 AC: 46AN: 152364Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74508
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 31, 2023 | Variant summary: GP1BA c.256C>T (p.Leu86Phe) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00024 in 249204 control chromosomes, predominantly at a frequency of 0.0033 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 6-fold of the estimated maximal expected allele frequency for a pathogenic variant in GP1BA causing Bernard Soulier Syndrome phenotype (0.00059). Moreover, the variant has been reported at a frequency of 0.040 including 93 homozygotes in the ToMMo 54KJPN dataset of Japanese control individuals. These data strongly suggest that the variant is a benign polymorphism found primarily in populations of East Asian origin, and more specifically, in individuals of Japanese ancestry. To our knowledge, no occurrence of c.256C>T in individuals affected with Bernard Soulier Syndrome have been reported. Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as likely benign, and one submitter classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 12, 2017 | - - |
Bernard Soulier syndrome;C1280798:Pseudo von Willebrand disease;C1847711:Nonarteritic anterior ischemic optic neuropathy, susceptibility to;C3277076:Bernard-Soulier syndrome, type A2, autosomal dominant Uncertain:1
Uncertain significance, no assertion criteria provided | research | Division of Human Genetics, Children's Hospital of Philadelphia | Dec 18, 2015 | - - |
GP1BA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 21, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at